Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Scleroproteins – e.g. – fibroin – elastin – silk – etc.
Patent
1995-04-07
1997-08-12
Feisee, Lila
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Scleroproteins, e.g., fibroin, elastin, silk, etc.
4241331, 4241351, A61K 39395
Patent
active
056567308
ABSTRACT:
The present invention relates to a stabilized protein composition comprising a monomeric protein and a storage-stabilizing amount of sucrose, histidine or glycine, which is sufficient to inhibit aggregation of the protein molecules during freeze/thaw cycles, and methods therefor. More particularly, this invention relates to pharmaceutically-acceptable, single-chain antigen-binding protein compositions having increased frozen-storage stability, especially to freeze/thaw cycles.
REFERENCES:
patent: 3950513 (1976-04-01), Jenson
patent: 4496537 (1985-01-01), Kwan
patent: 4597966 (1986-07-01), Zolton et al.
patent: 4645830 (1987-02-01), Yasushi et al.
patent: 4704692 (1987-11-01), Ladner
patent: 4777043 (1988-10-01), Bennett et al.
patent: 4806524 (1989-02-01), Kawaguchi et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5096885 (1992-03-01), Pearlman et al.
patent: 5260203 (1993-11-01), Ladner et al.
patent: 5358708 (1994-10-01), Patel
L. Stanford Lee, "Protein Folding and Polymerization study with a Recombinant Single Chain Antibody", The FASEB Journal, Experimental Biology 95, Abstracts 1-3621, Atlanta Georgia (Apr. 9-13, 1995), Abstract 2377.
Crowe et al 1987 Biochem. J. vol. 242:1-10.
Adams et al., Highly Specific in Vivo Tumor Targeting by Monovalent and Divalent forms of 741F8 Anti-c-erbB-2 Single-Chain Fv.sub.1, Cancer Research 53:4026-4034 (Sep. 1993).
Buchner et al., Renaturation, Purification and Characterization of Recombinant F.sub.ab -Fragments Produced in Escherichia coli, Bio/Technology 9:157-162 (Feb. 1991).
Buchner et al., A method for Increasing the Yield of Properly Folded Recombinant Fusion Proteins: Single-Chain Immonotoxins from Renaturation of Bacterial Inclusion Bodies, Analytical Biochemistry 205:263-270 (1992).
Colcher, et al. In Vivo Tumor Targeting of a Recombinant Single-Chain Antigen-Binding Protein, J. Natl. Cancer Inst. 82:1191-1197 (Jul. 1990).
Colombo et al., Protein Solvation in Allosteric Regulation: A Water Effect on Homoglobin, Science 256:655-659 (May 1992).
Hollinger et al., "Diabodies": Small Bivalent and Bispecific Antibody Fragments, Proc. Nat'l Acad. Sci. USA 90:6444-6448 (Jul. 1993).
Levine, Oxidative Modification of Glutamine Synthetase, The Journal of Biological Chemistry 258:11828-11833 (Oct. 1983).
Mezes et al., Third Annual IBC Intern'l Conf. on Antibody Engineering, San Diego, CA, one page (1992).
Milenic et al., Construction, Binding Properties, Metabolism, and Tumor Targeting of a Single-Chain Fv Derived from the Pancarcinoma Monoclonal Antibody CC49, Cancer Res. 51:6363-6371 (Dec. 1991).
Muller et al., Ligand Binding to Anti-Fluorescyl Antibodies: Stability of the Antigen Binding Site, Biochemistry 33:6221-6227 (May 1994).
Newton et al., Expression and Characterization of Recombinant Human Eosinophil-derived Neurotoxin and Eosinophil-derived Neurotoxin-Anti-transferrin Receptor sFv, The Journal of Biological Chemistry 269:26739-26745 (Oct. 1994).
Pantoliano et al., Conformational Stability, Folding, and Ligand-Binding Affinity of Single-Chain Fv Immunoglobulin Fragments Expressed in Escherichia Coli, Biochemistry 30:10117-10125 (1991).
Rand, Raising Water to New Heights, Science 256:618 (May 1992).
Sawyer et al., The Effects of Induction Conditions on Production of a Soluble Anti-Tumor sFv in Escherichia coli, Protein Engineering 7:1401-1406 (Aug. 1994).
Wang et al., Parenteral Formulations of Proteins and Peptides: Stability and Stabilizers, Journal of Parenteral Science & Technology 42:S12-S13, Supplement (1988).
Weidner et al., Molecular Stabilization Effects of Interactions between Anti-Metatype Antibodies and Liganded Antibody, The Journal of Biological Chemistry 267:10281-10288 (May 1992).
Whitlow et al., Single-Chain Fv Proteins and Their Fusion Proteins, Methods: A Companion to Methods in Enzymology 2:97-105 (Apr. 1991).
Whitlow et al., An Improved Linker for Single-Chain Fv with Reduced Aggregation and Enhanced Proteolytic Stability, Protein Engng. 6:989-995 (1993).
Whitlow et al., Multivalent Fvs: Chaterization of Single-Chain Fv Oligomers and Preparation of a Bispecific Fv, Protien Engineering 7:1017-1026 (Aug. 1994).
Enzon Inc.
Feisee Lila
Reeves Julie E.
LandOfFree
Stabilized monomeric protein compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized monomeric protein compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized monomeric protein compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-161412